News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Staff September 11, 2023 Iframe sync Post navigation Previous: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNext: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors More Stories Healthcare News Pharmaceutical GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience Staff December 15, 2025 Healthcare News Pharmaceutical New National Alliance Launches to Address Health Workforce Shortages in Underserved Communities Staff December 15, 2025 Brain Healthcare News Pharmaceutical Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million Staff December 15, 2025
